20 May 2013
Keywords: naispan, plus, statin, cost-effective, cvd, risk, management
Article | 02 October 2006
German drugmaker Merck KGaA says that the results of a new study indicate that raising high-density lipoprotein cholesterol levels with
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
2 October 2006
17 May 2013
© 2013 thepharmaletter.com